Berta Strulovici
Papers
5
Total Citations
139
H-Index
5
About
Berta Strulovici is a pioneering researcher in high-throughput screening (HTS) technologies and drug discovery automation, whose work has fundamentally advanced the infrastructure of modern pharmaceutical research. Her contributions span the development and optimization of cell-based functional assays, miniaturized biochemical screening platforms, and automated transfection methodologies, positioning her as a key innovator at the intersection of biology and screening technology. Among her most influential contributions is her early work on miniaturizing viral enzyme assays, including a Hepatitis C virus RNA polymerase system using advanced CCD imaging (29 citations), and her development of ultra-high-throughput GPCR binding assays in 1,536-well formats (22 citations), demonstrating her commitment to scaling and efficiency in drug target identification. Her research on metabotropic glutamate receptor antagonist screening (39 citations) and Division Arrest Technology for stable cell supply in HTS operations (33 citations) directly addressed practical bottlenecks in pharmaceutical screening pipelines. Her fully automated siRNA transfection method for genome-scale screens (16 citations) further reflects her forward-thinking approach to functional genomics. Collectively, her body of work has shaped how modern laboratories conduct large-scale biological screening, with cumulative citations reflecting sustained relevance across the drug discovery community.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5